These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4027900)

  • 1. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
    Alanko A; Heinonen E; Scheinin T; Tolppanen EM; Vihko R
    Cancer; 1985 Oct; 56(7):1696-700. PubMed ID: 4027900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA; Davidson AL; Kopel S; Schreibman B; Gelbfish JS; Degenshein GA; Herz BL; Cunningham JN
    Ann Surg; 1988 Jan; 207(1):75-9. PubMed ID: 3337566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.
    Paone JF; Abeloff MD; Ettinger DS; Arnold EA; Baker RR
    Surg Gynecol Obstet; 1981 Jan; 152(1):70-4. PubMed ID: 7455895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
    Heinonen E; Alanko A; Gröhn P; Rissanen P
    Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
    Ravdin PM; Green S; Dorr TM; McGuire WL; Fabian C; Pugh RP; Carter RD; Rivkin SE; Borst JR; Belt RJ
    J Clin Oncol; 1992 Aug; 10(8):1284-91. PubMed ID: 1634918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen.
    Bezwoda WR; Esser JD; Dansey R; Kessel I; Lange M
    Cancer; 1991 Aug; 68(4):867-72. PubMed ID: 1855186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic and therapeutic significance of steroid receptors in invasive breast cancer].
    Wyss P; Rageth JC; Unger C; Hochuli E
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):611-6. PubMed ID: 1294437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer in postmenopausal patients: Impact of age.
    Abu Rabi Z; Zoranovic T; Milovanovic J; Todorovic-Rakovic N; Nikolic-Vukosavljevic D
    J BUON; 2015; 20(3):723-9. PubMed ID: 26214623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of hormone receptors in breast cancer.
    Morimoto T; Komaki K; Yamamoto H; Yamakawa T; Tanaka T; Sonoo H; Monden Y
    J Surg Oncol; 1988 Oct; 39(2):101-7. PubMed ID: 3172790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
    Luoh SW; Ramsey B; Park B; Keenan E
    Breast J; 2014; 20(1):46-52. PubMed ID: 24261828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor status of breast cancer metastases.
    Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.